ストックスクリーナーアプリを入手
38.03
0.57%
0.22
前日終値:
$37.81
開ける：
$38.14
24時間の取引高:
90,174
Relative Volume:
0.14
時価総額：
$2.29B
収益：
-
当期純損益:
$-146.66M
株価収益率:
-13.81
EPS:
-2.7541
ネットキャッシュフロー:
$-133.21M
1週間 パフォーマンス:
-5.22%
1か月 パフォーマンス:
+19.58%
6か月 パフォーマンス:
-37.79%
1年 パフォーマンス:
-28.15%
1日の値動き範囲:
$37.93
$39.45
1週間の範囲:
$34.38
$40.15
52週間の値動き範囲:
$26.20
$63.50
Apogee Therapeutics Inc Stock (APGE) Company Profile
APGE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
APGE
Apogee Therapeutics Inc
|
38.18 | 2.29B | 0 | -146.66M | -133.21M | -2.7541 |
|
VRTX
Vertex Pharmaceuticals Inc
|
433.53 | 128.25B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
544.12 | 63.70B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ARGX
Argen X Se Adr
|
564.47 | 39.07B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
256.74 | 33.27B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ONC
Beigene Ltd Adr
|
235.06 | 27.60B | 3.81B | -644.79M | -669.77M | -6.24 |
Apogee Therapeutics Inc Stock (APGE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-13 | 開始されました | Citigroup | Buy |
| 2024-11-25 | 開始されました | Canaccord Genuity | Buy |
| 2024-05-10 | 開始されました | BofA Securities | Buy |
| 2023-12-20 | 開始されました | BTIG Research | Buy |
| 2023-08-08 | 開始されました | Guggenheim | Buy |
| 2023-08-08 | 開始されました | Jefferies | Buy |
| 2023-08-08 | 開始されました | Stifel | Buy |
| 2023-08-08 | 開始されました | TD Cowen | Outperform |
| 2023-08-08 | 開始されました | Wedbush | Outperform |
すべてを表示
Apogee Therapeutics Inc (APGE) 最新ニュース
APGE August 15th Options Begin Trading - Nasdaq
Stifel maintains $95 target on Apogee Therapeutics stock By Investing.com - Investing.com Nigeria
(APGE) On The My Stocks Page - news.stocktradersdaily.com
Wall Street Analysts Believe Apogee Therapeutics Inc. (APGE) Could Rally 134%: Here's is How to Trade - Yahoo Finance
Apogee Therapeutics, Inc. (NASDAQ:APGE) Holdings Lowered by Invesco Ltd. - Defense World
Apogee Therapeutics to Participate at the Bank of America 2025 Health Care Conference - The Manila Times
Apogee Therapeutics to Participate at the Bank of America 2025 Health Care Conference - GlobeNewswire Inc.
Wells Fargo & Company MN Lowers Stock Holdings in Apogee Therapeutics, Inc. (NASDAQ:APGE) - Defense World
JPMorgan Chase & Co. Has $1.69 Million Position in Apogee Therapeutics, Inc. (NASDAQ:APGE) - Defense World
It would be worthwhile to take a closer look at Apogee Therapeutics Inc (APGE) - uspostnews.com
Companies Like Apogee Therapeutics (NASDAQ:APGE) Are In A Position To Invest In Growth - Yahoo Finance
First Week of APGE June 20th Options Trading - Nasdaq
When (APGE) Moves Investors should Listen - news.stocktradersdaily.com
Apogee Therapeutics, Inc. (NASDAQ:APGE) Receives Consensus Recommendation of “Buy” from Brokerages - Defense World
Geode Capital Management LLC Has $36.98 Million Stake in Apogee Therapeutics, Inc. (NASDAQ:APGE) - Defense World
Apogee Therapeutics: Engineering Biologic Dominance (NASDAQ:APGE) - Seeking Alpha
Vanguard Group Inc. Sells 29,445 Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE) - Defense World
Commonwealth Equity Services LLC Buys Shares of 4,906 Apogee Therapeutics, Inc. (NASDAQ:APGE) - Defense World
KLP Kapitalforvaltning AS Acquires New Holdings in Apogee Therapeutics, Inc. (NASDAQ:APGE) - Defense World
Insider Purchases Worth US$990.8k See Losses As Apogee Therapeutics Market Value Drops To US$1.9b - simplywall.st
Corebridge Financial Inc. Cuts Stock Position in Apogee Therapeutics, Inc. (NASDAQ:APGE) - Defense World
Apogee Therapeutics’ chief medical officer sells $139,801 in stock By Investing.com - Investing.com South Africa
Apogee Therapeutics’ chief medical officer sells $139,801 in stock - Investing.com Australia
Teacher Retirement System of Texas Purchases 1,848 Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE) - Defense World
Swiss National Bank Raises Stock Position in Apogee Therapeutics, Inc. (NASDAQ:APGE) - Defense World
Brokerages Set Apogee Therapeutics, Inc. (NASDAQ:APGE) Target Price at $92.17 - The AM Reporter
Analysts Set Apogee Therapeutics, Inc. (NASDAQ:APGE) PT at $92.17 - Defense World
Is Apogee Therapeutics (APGE) Among the Best IPO Stocks to Buy in 2025? - Insider Monkey
(APGE) Trading Advice - news.stocktradersdaily.com
Charles Schwab Investment Management Inc. Sells 2,936 Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE) - Defense World
12 Best IPO Stocks to Buy in 2025 - Insider Monkey
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Bank of New York Mellon Corp Decreases Position in Apogee Therapeutics, Inc. (NASDAQ:APGE) - Defense World
May 16th Options Now Available For Apogee Therapeutics (APGE) - Nasdaq
(APGE) Trading Signals - Stock Traders Daily
Apogee Therapeutics (NASDAQ:APGE) Coverage Initiated at Citigroup - Defense World
Victory Capital Management Inc. Sells 123,296 Shares of Apogee Therapeutics, Inc. (NASDAQ:APGE) - Defense World
Apogee Therapeutics (NASDAQ:APGE) Trading Up 4.5%What's Next? - MarketBeat
Citigroup Initiates Coverage of Apogee Therapeutics (APGE) with Buy Recommendation - Nasdaq
Citigroup Initiates Apogee Therapeutics at Buy With $95 Price Target -March 13, 2025 at 07:14 am EDT - Marketscreener.com
Apogee Therapeutics initiated with a Buy at Citi - TipRanks
Zevra Therapeutics Inc (ZVRA) gets rating Resumed from Cantor Fitzgerald - Knox Daily
Apogee Therapeutics (NASDAQ:APGE) Given Outperform Rating at Wedbush - Defense World
Apogee Therapeutics signs manufacturing deal with Samsung Biologics By Investing.com - Investing.com Canada
Apogee Therapeutics signs manufacturing deal with Samsung Biologics - Investing.com India
Apogee Therapeutics IncEnters Master Services Agreement With Samsung Biologics - Marketscreener.com
Apogee Therapeutics Inc (APGE) 財務データ
収益
当期純利益
現金流量
EPS
5.73%
1.07%
大文字化:
|
ボリューム (24 時間):